Difficulty: Medium
Average Score: 86%
Practice
A patient has been referred to you because of recent-onset ventricular ectopy, second degree AV nodal block, chromatopsia, and other extracardiac signs and symptoms of digoxin intoxication; He is treated with furosemide and digoxin for his heart failure. Blood tests show that serum digoxin levels are well within a normal range. We believe the problems are diuretic-induced. Which of the following does the diuretic most likely do to account for the digoxin toxicity?
Correct answer
B
Rationale
The correct answer is B) Caused hypokalemia.
Explanation:
Hypokalemia, or low potassium levels, can potentiate the toxic effects of digoxin. Digoxin competes with potassium for binding sites on the sodium-potassium pump in cardiac myocytes. Low potassium levels increase the binding of digoxin to these sites, leading to increased intracellular calcium concentrations and enhancing the toxic effects of digoxin on the heart, manifesting as ventricular ectopy and AV nodal block.
Why others are wrong:
A) Caused hypercalcemia: This is unlikely as hypercalcemia would not enhance digoxin toxicity.
C) Caused hyponatremia: While electrolyte imbalances can contribute to digoxin toxicity, hyponatremia is not directly linked to the potentiation of digoxin toxicity like hypokalemia.
D) Displaced digoxin from tissue binding sites: This option is incorrect because displacing digoxin from tissue binding sites would not lead to increased toxicity.
Educational context:
Understanding the interactions between medications like digoxin and diuretics is crucial in clinical practice, especially when managing patients with heart failure. Healthcare providers need to be aware of how electrolyte imbalances, such as hypokalemia induced by diuretics, can influence the effects of medications like digoxin to provide safe and effective care to their patients.
Explanation:
Hypokalemia, or low potassium levels, can potentiate the toxic effects of digoxin. Digoxin competes with potassium for binding sites on the sodium-potassium pump in cardiac myocytes. Low potassium levels increase the binding of digoxin to these sites, leading to increased intracellular calcium concentrations and enhancing the toxic effects of digoxin on the heart, manifesting as ventricular ectopy and AV nodal block.
Why others are wrong:
A) Caused hypercalcemia: This is unlikely as hypercalcemia would not enhance digoxin toxicity.
C) Caused hyponatremia: While electrolyte imbalances can contribute to digoxin toxicity, hyponatremia is not directly linked to the potentiation of digoxin toxicity like hypokalemia.
D) Displaced digoxin from tissue binding sites: This option is incorrect because displacing digoxin from tissue binding sites would not lead to increased toxicity.
Educational context:
Understanding the interactions between medications like digoxin and diuretics is crucial in clinical practice, especially when managing patients with heart failure. Healthcare providers need to be aware of how electrolyte imbalances, such as hypokalemia induced by diuretics, can influence the effects of medications like digoxin to provide safe and effective care to their patients.